Harrow (HROW) EV to EBIT (2010 - 2026)
Harrow (HROW) posted EV to EBIT of 136.98 for Q2 2026, down 148.09% on a QoQ basis from 55.21 in Q1 2026, and down 246.33% year-over-year from 93.61 in Q2 2025.
Analysis
Harrow (HROW) EV to EBIT (2010 - 2026) Analysis & Trends
Harrow has reported EV to EBIT for 17 years, with the latest figure at 136.98 in Q2 2026.
- On a quarterly basis, EV to EBIT fell 246.33% year-over-year to 136.98 in Q2 2026; TTM through Jun 2026 was 548.46, a 839.38% decrease from a year earlier, with the FY2025 full-year figure at 57.38, down 55.89% from the prior year.
- EV to EBIT was 136.98 for Q2 2026 at Harrow, down from 55.21 in the prior quarter.
- The five-year high for EV to EBIT was 1156.8 in Q3 2024, with the low at 2950.12 in Q3 2022.
- Average EV to EBIT over 5 years is 21.93, with a median of 87.41 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: EV to EBIT tumbled 6118.21% in 2022, then soared 692.33% in 2023.
- Over 5 years, EV to EBIT stood at 190.74 in 2022, then soared by 66.58% to 63.75 in 2023, then jumped by 239.56% to 88.96 in 2024, then climbed by 26.24% to 112.3 in 2025, then slumped by 221.97% to 136.98 in 2026.
- The last three EV to EBIT figures came in at 136.98 (Q2 2026), 55.21 (Q1 2026), and 112.3 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn |
| 2 | AbbVie | 442.18 Bn | 435.61 Bn | 12.70 Bn |
| 3 | Merck | 366.59 Bn | 359.45 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.49 Bn | 258.80 Bn | 11.24 Bn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn |
| 10 | Harrow | 1.40 Bn | 1.32 Bn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -136.98 |
| Mar 31, 2026 | -55.21 |
| Dec 31, 2025 | 112.30 |
| Sep 30, 2025 | 115.93 |
| Jun 30, 2025 | 93.61 |
| Mar 31, 2025 | -78.47 |
| Dec 31, 2024 | 88.96 |
| Sep 30, 2024 | 1,156.80 |
| Jun 30, 2024 | 437.81 |
| Mar 31, 2024 | -56.55 |
| Dec 31, 2023 | -63.75 |
| Sep 30, 2023 | 246.79 |
| Jun 30, 2023 | 232.33 |
| Mar 31, 2023 | 503.11 |
| Dec 31, 2022 | -190.74 |
| Sep 30, 2022 | -2,950.12 |
| Jun 30, 2022 | 85.85 |
| Mar 31, 2022 | 63.50 |
| Dec 31, 2021 | -103.37 |
| Sep 30, 2021 | -47.44 |